Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy

Journal of Psychopharmacology

Volumn 26, Issue 3, 2012, Pages 368-373

  Rybakowski, Janusz K ^a   Czerski, Piotr ^a   Dmitrzak Weglarz, Monika ^a   Kliwicki, Sebastian ^a   Leszczynska Rodziewicz, Anna ^a   Permoda Osip, Agnieszka ^a   Skibinska, Maria ^a   Suwalska, Aleksandra ^a   Szczepankiewicz, Aleksandra ^a   Hauser, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bipolar disorder; lithium; pharmacogenetics

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT; VALPROIC ACID;

5HT2A GENE; 5HT2C GENE; 5HTT GENE; ADULT; AGED; ARTICLE; BDNF GENE; BIPOLAR DISORDER; COMT GENE; CONTROLLED STUDY; DNA POLYMORPHISM; DRD1 GENE; DRD2 GENE; DRD3 GENE; DRD4 GENE; DRUG EFFICACY; FEMALE; FYN GENE; GENE; GENE ACTIVITY; GENE FUNCTION; GENETIC ASSOCIATION; GRIN2B GENE; GSK 3 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MMP 9 GENE; NTRK2 GENE; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESISTANCE; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, DOPAMINE D1; RECURRENCE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84857807586     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111415736     Document Type: Article

References (41)

1. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet. 1997 ; 6: 577-582 (Pubitemid 27142107)
2. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open-label trial. Lancet. 2010 ; 375: 385-395
3. Cichon S, Nothen MM, Erdmann J, Propping P. Detection of four polymorphic sites in the human dopamine D1 receptor gene (DRD1). Hum Mol Genet. 1994 ; 3: 209 (Pubitemid 24038174)
4. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, Czerski PM, Leszczynska-Rodziewicz A, Kapelski P, et al. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology. 2006 ; 53: 51-56
5. Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Szczepankiewicz A, et al. Association studie of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics. 2008 ; 9: 1595-1603
6. Drago A, De Ronchi D, Serretti A. Pharmacogenetics of antidepressant response: an update. Hum Genomics. 2009 ; 3: 257-274
7. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet. 2000 ; 96: 56-60 (Pubitemid 30077651)
8. First MB, Spitzer RL, Gibbon M, Williams J Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press ; 1996 :
9. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology. 2001 ; 158: 100-106
10. Geddes JR, Burgess S, Kawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004 ; 161: 217-222 (Pubitemid 38419270)
11. Green EK, Raybould R, Macgregor S, Hyde S, Young AH, O'Donovan MC, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry. 2006 ; 188: 21-25 (Pubitemid 43021922)
12. Grof P Lithium: 50 Years of Psychopharmacology, New Perspectives in Biomedical and Clinical Research. Birch NJ Gallicchio VS Becker RW, ed. Cheshire, Connecticut: Weidner Publishing Group ; 1999: 36-51.
13. Hartigan G. The use of lithium salts in affective disorders. Br J Psychiatry. 1963 ; 109: 810-814
14. Hauser J, Leszczynska A, Samochowiec J, Czerski PM, Ostapowicz A, Chlopocka M, et al. Association analysis of the insertion/deletion polymorphism in serotonin transporter gene in patients with affective disorder. Eur Psychiatry. 2003 ; 18: 129-132 (Pubitemid 36644315)
15. Ishiguro H, Saito T, Shibuya H, Toru M, Arinami T. Mutation and association analysis of the FYN kinase gene with alcoholism and schizophrenia. Am J Med Genet. 2000 ; 96: 716-720
16. Jönsson EG, Ivo R, Forslund K, Mattila-Evenden M, Rylander G, Cichon S, et al. No association between a promoter dopamine D(4) receptor gene variant and schizophrenia. Am J Med Genet. 2001 ; 105: 525-528 (Pubitemid 32729820)
17. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry. 2001 ; 6: 83-86 (Pubitemid 32096070)
18. Lannfelt L, Sokoloff P, Martres M, Pilon C, Giros B, Jonsson E, et al. Amino-acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet. 1992 ; 2: 249-256
19. Lappalainen J, Zhang L, Dean M, Oz M, Ozaki N, Yu DH, et al. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics. 1995 ; 27: 274-279
20. Li T, Valllada H, Curtis D, Arranz M, Xu K, Cai G, et al. Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics. 1997 ; 7: 349-353 (Pubitemid 27427543)
21. Muller DJ, deLuca V, Sicard T, King N, Strauss J, Kennedy JL. Brain-derived neurotrophic factor gene and rapid-cycling bipolar disorders: family-based association study. Br J Psychiatry. 2006 ; 189: 317-323 (Pubitemid 44606744)
22. Neves FS, Silveira G, Romano-Silva MA, Malloy-Diniz L, Ferreira AA, DeMarco L, et al. Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients?. Am J Med Genet. 2008 ; 147B: 114-116
23. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet. 2002 ; 71: 651-655 (Pubitemid 34970137)
24. Nivoli AMA, Murru A, Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder?. Neuropsychobiology. 2010 ; 62: 27-35
25. Ohtsuki T, Sakurai K, Dou H, Toru M, Yamakawa-Kobayashi K, Arinami T. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol Psychiatry. 2001 ; 6: 211-216 (Pubitemid 32187872)
26. Russ C, Lovestone S, Powell JF. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late-onset Alzheimer's disease. Mol Psychiatry. 2001 ; 6: 320-324 (Pubitemid 32275679)
27. Rybakowski JK, Chopocka-Woniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s. Bipolar Disord. 2001 ; 3: 63-67 (Pubitemid 32492592)
28. Rybakowski JK, Skibinska M, Leszczynska-Rodziewicz A, Kaczmarek L, Hauser J. Matrix metalloproteinase-9 (MMP-9) gene and bipolar mood disorder. Neuromolecular Med. 2009 ; 11: 128-132
29. Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A, et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry. 2005 ; 38: 166-170 (Pubitemid 41059223)
30. Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics J. 2001 ; 1: 71-77 (Pubitemid 33757986)
31. Severino G, Congiu D, Serelli C, De Lisa R, Chillotti C, Del Zompo M, et al. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am J Med Genet. 2005 ; 134B: 37-38 (Pubitemid 40411106)
32. Shaldubina A, Agan G, Belmaker RH. The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry. 2001 ; 25: 855-866 (Pubitemid 32374970)
33. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry. 2002 ; 7: 579-593
34. Stoltenberg SF, Twitchell GR, Hanna GL, Cook EH, Fitzgerald HE, Zucker RA, et al. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am J Med Genet. 2002 ; 114: 230-234 (Pubitemid 34160477)
35. Szczepankiewicz A, Rybakowski JK, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Wilkosc M, et al. FYN kinase gene: another glutamatergic gene associated with bipolar disorder?. Neuropsychobiology. 2009 ; 59: 178-183
36. Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Dmitrzak-Weglarz M, et al. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry. 2006 ; 7: 158-161 (Pubitemid 44132541)
37. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, Marineau C, et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry. 2001 ; 6: 570-578 (Pubitemid 32772566)
38. Vepsäläinen S, Castren E, Helisalmi S, Iivonen S, Mannermaa A, Lehtovirta M, et al. Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J Neurol. 2005 ; 252: 423-428 (Pubitemid 40584812)
39. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr Res. 2006 ; 84: 29-35 (Pubitemid 44255717)
40. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet. 1999 ; 105: 418-423
41. Zhang Z, Lindpaintner K, Che R, He Z, Wang P, Feng G, et al. The Val/met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis. J Neural Transm. 2009 ; 116: 1193-1200